Colesevelam (Welchol,) might not be a first choice for many clinicians in the treatment of type 2 diabetes; however, a post hoc analysis of 3 large randomized controlled trials reveals that it might be a good option as an add-on therapy for patients with both type 2 diabetes and high cholesterol.…

Two phase 3 studies have found that a combination of naltrexone SR/bupropion SR can produce significant weight loss in overweight and obese women, regardless of menopausal status.…

A review of official reports of bad drug reactions is revealing more signs that people taking the diabetes drug Actos® are at higher risk of developing bladder cancer.…

While you are reading this, I am in Las Vegas for the American Society of Consultant Pharmacists meeting. These pharmacists work with clinicians and residents in LTC and AL facilities and are specialists in geriatric medicine: they have their work cut out for them when it comes to managing diabetes. …

Edited by Trisha Dunning AM, RN, MEd, PhD, CDE, FRCNA and Glenn Ward MBBS, BSc, DPhil (Oxon), FRACP, FRCPath This week, we continue with Part 4 of our special series of case discussions. CASE DISCUSSION: Mr. ZM Mr. ZM was referred to an endocrinologist by his GP at the request …

This week we continue Dr. Aaron Vinik’s slide series on Diabetic Neuropathies….

This week, a new study from Surescripts found that the use of electronic prescribing in 2010 increased by 72% over 2009, climbing to 326 million up from 190 million e-prescriptions in 2009. By the end of 2010, approximately 25% of eligible prescriptions were prescribed electronically, and 91% of all pharmacies …

The Joslin 50-Year Medalist Study AARON VINIK, MD, PHD, FCP, MACP The Joslin Gold Medalists comprise 351 U.S. residents who have survived with type 1 diabetes for more than 50 years. A high proportion of Medalists remain free from proliferative diabetic retinopathy (PDR) (42.6%), nephropathy (86.9%), neuropathy (39.4%), or cardiovascular …

  Diamyd Medical reports that results from its European Phase III study with the antigen-based therapy Diamyd® did not meet the primary efficacy endpoint of preserving beta cell function at 15 months, as measured by meal stimulated C-peptide, in newly diagnosed Type 1 diabetes patients.

  Now available for Pen Needles. 100 Premium Quality UltiCare Pen Needles is available in the Dispense & Dispose packaging system. UltiGuard™ is the complete home pen needle dispense and dispose system. The tamperproof container provides security and safety. Premium UltiCare™ pen needles are shipped and stored within the container until needed. …